ReviewFrontiers in microbiology2026
Key directions of fundamental research on bacteriophage Receptor Binding Proteins with applied potential.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past decade, interest in research on bacteriophage Receptor Binding Proteins (RBPs) of tailed bacteriophages has increased substantially, reflecting a broader resurgence in phage research. Once underestimated, RBPs have now become the focus of extensive investigation, largely due to their promising applications in pathogen diagnostics, host-range engineering for improved phage therapy, and the development of tailocins, protein-based antibacterial agents capable of inhibiting or eliminating bacterial cells. This review aims to synthesize current knowledge on RBPs function and applications, with particular emphasis on their translational potential. We systematically analyzed recent literature, focusing on structural, biochemical, and functional studies that elucidate mechanisms of host recognition and explore emerging biotechnological and therapeutic uses. The reviewed studies highlight significant advances in understanding RBPs specificity, modular architecture, and adaptability. These features enable targeted bacterial recognition and manipulation of host range. Furthermore, we demonstrate that RBPs can be effectively engineered to be repurposed for diagnostic and antimicrobial applications. Together, these findings position RBPs as a foundational platform for next-generation phage-based technologies and their translation into clinical and industrial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.